Dr. Sylvia Adams

Dr. Sylvia Adams, MD, is a widely respected medical oncologist specializing in the treatment of breast cancer and the development of novel immunotherapies. She serves as Director of the Breast Cancer Center at NYU Langone’s Perlmutter Cancer Center and is a Professor in the Department of Medicine at NYU Grossman School of Medicine. Dr. Adams received her medical degree from the Free University of Berlin in Germany and completed her internal medicine residency and hematology-oncology fellowship training at Albert Einstein College of Medicine in New York. She is board-certified in Internal Medicine and Medical Oncology.

Dr. Adams is internationally known for her leadership in breast cancer immunotherapy research. Her work has focused on understanding the tumor microenvironment and the role of immune checkpoint inhibitors in triple-negative breast cancer. She has led numerous clinical trials that have helped define new standards of care, contributing significantly to the advancement of immune-based treatment strategies. Her research has been widely published in leading oncology journals, and she remains at the forefront of integrating innovative science into clinical applications.

In addition to her clinical and research leadership, Dr. Adams is an active mentor and educator, training the next generation of oncologists and physician-scientists. She is a frequent speaker at national and international conferences and plays an advisory role in various oncology committees and consortia. Through her dedication to scientific advancement, compassionate care, and collaborative leadership, Dr. Adams continues to shape the evolving landscape of breast cancer treatment.